Chang and colleagues found that IL-17F is significantly higher in the bronchial biopsies from COPD patients (16 patients, mean age 53 years, 10 males, GOLD I 2 patients, II 8 patients, and III–IV 6 patients) compared to control subjects. Here, IL17F is linked to chronic obstructive pulmonary disease.